急性心肌梗死交感应激相关生物标志物研究进展

Biomarkers Related to Sympathetic Stress in Acute Myocardial Infarction

急性心肌梗死(AMI)作为常见的心血管疾病,发病率和死亡率呈逐年上升态势,严重危害着人们的生命健康。传统心血管生物标志物的临床应用,极大促进了AMI的诊断、风险分层、治疗和预后。寻找新型生物标志物并将其应用于AMI的临床实践仍是目前研究的重要方向。交感应激在AMI中发挥着重要作用。现就近年来有关交感应激相关生物标志物与AMI关系的研究进行总结,以探讨此类标志物用于AMI诊断、风险分层及预后的可行性。

As a common cardiovascular disease,acute myocardial infarction(AMI)has a rising incidence rate and mortality rate year by year,which seriously endangers people’s life and health.The clinical application of traditional cardiovascular biomarkers has greatly promoted the diagnosis,risk stratification,treatment,and prognosis of AMI.Finding new biomarkers and applying them to the clinical practice of AMI is still an important research direction at present.Sympathetic stress plays an important role in AMI.This article summarizes the research on the relationship between sympathetic stress-related biomarkers and AMI in recent years,in order to explore the feasibility of using such biomarkers for the diagnosis,risk stratification,and prognosis of AMI.